{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:01:56Z","timestamp":1793638916719,"version":"4.5.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T00:00:00Z","timestamp":1432771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ijpddr.2015.05.005","type":"journal-article","created":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T21:00:31Z","timestamp":1435611631000},"page":"92-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether\u2013lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya"],"prefix":"10.1016","volume":"5","author":[{"given":"Angela O.","family":"Achieng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peninah","family":"Muiruri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luicer A.","family":"Ingasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H.","family":"Opot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Juma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Redemptah","family":"Yeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bidii S.","family":"Ngalah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhards R.","family":"Ogutu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Andagalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoseah M.","family":"Akala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Kamau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2015.05.005_bib1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1475-2875-6-72","article-title":"The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya","volume":"6","author":"Amin","year":"2007","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A\u00a0molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2015.05.005_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib4","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1086\/320195","article-title":"High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1","volume":"183","author":"Babiker","year":"2001","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib5","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1128\/AAC.01313-06","article-title":"Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in\u00a0vitro antimalarial drug efficacy testing and application to clinical isolates","volume":"51","author":"Bacon","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0035-9203(97)90222-4","article-title":"Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria","volume":"91","author":"Bethell","year":"1997","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/infdis\/jiu141","article-title":"Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children","volume":"210","author":"Conrad","year":"2014","journal-title":"J. Infect. Dis"},{"key":"10.1016\/j.ijpddr.2015.05.005_bib8","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1073\/pnas.91.3.1143","article-title":"Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine","volume":"91","author":"Cowman","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM200101253440403","article-title":"A\u00a0molecular marker for chloroquine-resistant falciparum malaria","volume":"344","author":"Djimd\u00e9","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1046\/j.1365-2958.2000.01914.x","article-title":"Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum","volume":"36","author":"Duraisingh","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib12","doi-asserted-by":"crossref","first-page":"e64299","DOI":"10.1371\/journal.pone.0064299","article-title":"The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008\u20132011","volume":"8","author":"Eyase","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2015.05.005_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0035-9203(79)90220-7","article-title":"Chloroquine-resistant Plasmodium falciparum malaria in Kenya","volume":"73","author":"Fogh","year":"1979","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib14","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1128\/AAC.05102-11","article-title":"Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine","volume":"55","author":"Gadalla","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib15","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/infdis\/jiu358","article-title":"Directional selection at the pfmdr1, pfcrt, pfubp1 and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT","volume":"210","author":"Henriques","year":"2014","journal-title":"J.\u00a0Infect. Dis."},{"issue":"12","key":"10.1016\/j.ijpddr.2015.05.005_bib16","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1365-3156.2006.01742.x","article-title":"Amodiaquine resistance is not related to rare findings of pfmdr1 gene amplifications in Kenya","volume":"11","author":"Holmgren","year":"2006","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ijpddr.2015.05.005_bib18","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/AAC.00875-06","article-title":"Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria","volume":"51","author":"Humphreys","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib19","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/AAC.01607-06","article-title":"Assessment and continued validation of the malaria SYBR Green I-based fluorescence assay for use in malaria drug screening","volume":"51","author":"Johnson","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib20","first-page":"1352","article-title":"K13-Propeller polymorphisms in Plasmodium falciparum parasites from Sub-Saharan Africa","volume":"211","author":"Kamau","year":"2014","journal-title":"J.\u00a0Infect. Dis."},{"issue":"12","key":"10.1016\/j.ijpddr.2015.05.005_bib21","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1086\/375419","article-title":"Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after Cessation of chloroquine use in Malawi","volume":"187","author":"Kublin","year":"2003","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1086\/655659","article-title":"Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites","volume":"202","author":"Laufer","year":"2010","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2875-8-11","article-title":"Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia","volume":"8","author":"Lim","year":"2009","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib24","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/infdis\/jis747","article-title":"Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms","volume":"207","author":"Malmberg","year":"2013","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1475-2875-12-103","article-title":"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance\/resistance in Bagamoyo district, Tanzania","volume":"12","author":"Malmberg","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.actatropica.2012.05.007","article-title":"Changes in genotypes of Plasmodium falciparum human malaria parasite following withdrawal of chloroquine in Tiwi, Kenya","volume":"123","author":"Mang'era","year":"2012","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib27","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4269\/ajtmh.2011.11-0194","article-title":"Polymorphisms of molecular markers of antimalarial drug resistance and relationship with artesunate mefloquine combination therapy in patients with uncomplicated Plasmodium falciparum malaria in Thailand","volume":"85","author":"Muhamad","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib28","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1128\/AAC.00638-09","article-title":"In\u00a0vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1","volume":"53","author":"Mwai","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2125.1994.tb04271.x","article-title":"Pharmacokinetics of artemether after oral administration to healthy Thai males and patients with acute, uncomplicated falciparum malaria","volume":"37","author":"Na","year":"1994","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib31","doi-asserted-by":"crossref","first-page":"8308","DOI":"10.1038\/srep08308","article-title":"Analysis of major genome loci underlying artemisinin resistance and pfmdr1 copy number in pre- and post-ACTs in western Kenya","volume":"5","author":"Ngalah","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijpddr.2015.05.005_bib30","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMc0805011","article-title":"Evidence of artemisinin-resistant malaria in western Cambodia","volume":"359","author":"Noedl","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1475-2875-13-33","article-title":"Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study","volume":"13","author":"Ogutu","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/1475-2875-9-285","article-title":"Changing malaria intervention coverage, transmission and hospitalization in Kenya","volume":"9","author":"Okiro","year":"2010","journal-title":"Malar. J."},{"issue":"3","key":"10.1016\/j.ijpddr.2015.05.005_bib34","first-page":"152","article-title":"Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya","volume":"4","author":"Okombo","year":"2014"},{"key":"10.1016\/j.ijpddr.2015.05.005_bib36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1475-2875-8-89","article-title":"A\u00a0systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria","volume":"8","author":"Picot","year":"2009","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib37","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1128\/AAC.43.12.2943","article-title":"The pfmdr1 gene is associated with a multidrugresistant phenotype in Plasmodium falciparum from the western border of Thailand","volume":"43","author":"Price","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib38","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","article-title":"Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number","volume":"364","author":"Price","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2015.05.005_bib39","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.trstmh.2008.01.021","article-title":"Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates","volume":"102","author":"Rason","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib40","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/35002615","article-title":"Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum","volume":"403","author":"Reed","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2015.05.005_bib41","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1365-3156.2000.00643.x","article-title":"Using evidence to change antimalarial drug policy in Kenya","volume":"5","author":"Shretta","year":"2000","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ijpddr.2015.05.005_bib42","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1365-2958.2005.04729.x","article-title":"pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum","volume":"57","author":"Sidhu","year":"2005","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib43","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/427997","article-title":"In\u00a0vivo selection of Plasmodium falciparum pfmdr1 86 N coding alleles by artemether-lumefantrine (Coartem)","volume":"191","author":"Sisowath","year":"2005","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib44","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-3156.2007.01843.x","article-title":"The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa","volume":"12","author":"Sisowath","year":"2007","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ijpddr.2015.05.005_bib45","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1086\/596738","article-title":"In\u00a0vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa","volume":"199","author":"Sisowath","year":"2009","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib47","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1128\/AAC.01413-09","article-title":"Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquinesulfadoxine-pyrimethamine but not dihydroartemisininpiperaquine in Burkina Faso","volume":"54","author":"Some","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib48","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1086\/650301","article-title":"In\u00a0vivo parasitological measures of artemisinin susceptibility","volume":"201","author":"Stepniewska","year":"2010","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib49","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/infdis\/jiu467","article-title":"Absence of putative artemisinin resistance mutations among plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study","volume":"211","author":"Taylor","year":"2014","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib50","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2015.05.005_bib51","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1086\/497337","article-title":"Amplification of Plasmodium falciparum multidrug resistance Gene 1 in isolates from Gabon","volume":"192","author":"Uhlemann","year":"2005","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib52","doi-asserted-by":"crossref","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","article-title":"Polymorphisms in plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine","volume":"91","author":"Venkatesan","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib53","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1086\/651949","article-title":"Multiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in Cambodia","volume":"201","author":"Vinayak","year":"2010","journal-title":"J.\u00a0Infect. Dis."},{"issue":"5874","key":"10.1016\/j.ijpddr.2015.05.005_bib55","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.1155165","article-title":"Qinghaosu (artemisinin): the price of success","volume":"320","author":"White","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2015.05.005_bib56","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00003088-199937020-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine","volume":"37","author":"White","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijpddr.2015.05.005_bib57","series-title":"Status Report on Artemisinin Resistance","author":"W.H.O","year":"2014"},{"key":"10.1016\/j.ijpddr.2015.05.005_bib59","series-title":"World Malaria Report","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.ijpddr.2015.05.005_bib60","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1475-2875-13-114","article-title":"Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009","volume":"13","author":"Zwang","year":"2014","journal-title":"Malar. J."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320715300014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320715300014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:45:25Z","timestamp":1761921925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320715300014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S2211320715300014"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2015.05.005","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether\u2013lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2015.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}